Extragastral side effects of non-steroidal anti-inflammatory drugs;Extragastrale nebenwirkungen nicht-steroidaler antirheumatika

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 21, 1998, Pages 669-673

  Jaspersen, D ^a,b  

^a Städtisches Klinikum Fulda

^b KLINIKUM FULDA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

PAIN; REVIEW; STEROID THERAPY;

EID: 0032557393     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024036     Document Type: Review

References (56)

1. Allison, M.C., A. G. Howatson, C. J. Torrance, F. D. Lee, R. I. Russel: Gastrointestinal damage associated with the use of non-steroidal anti-inflammatory drugs. New Engl. J. Med. 327 (1992), 749-754.
2. Banerjee, A. K., T. J. Peters: Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat. Gut 31 (1990), 1358-1364.
3. Bjarnason, I., G. Zanelli, P. Prouse, P. Wiliams, M. J. Gumpel, A. J. Levi: Effect of non-steroidal anti-inflammatory drugs on the human small intestine. Drugs 32 (1986), 35-41.
4. Bjarnason, I., J. Hayllar, A. MacPherson, A. J. Russel: Side effects of non-steroidal anti-inflammatory drugs on the small intestine in humans. Gastroenterology 104 (1993), 1832-1847.
5. Bjarnason, I., A. B. Price, G. Zanelli, P. Smethurst, M. Burke: Clinicopathological features of non-steroidal anti-inflammatory drug-induced small intestinal strictures. Gastroenterology 94 (1988), 1070-1074.
6. Bjarnason, I., P. Williams, P. Smethurst, T. J. Peters, A. J. Levi: The effect of NSAIDs and prostaglandines on the permeability of the human small intestine. Gut 27 (1986), 1292-1297.
7. Bjarnason, I., G. Zanelli, T. Smith, P. Prouse, P. Smethurst: Nonsteroidal anti-inflammatory-drug-induced intestinal inflammation in humans. Gastroenterology 93 (1987), 480-489.
8. Bjarnason, I., G. Zanelli, P. Prouse, P. Smethurst, T. Smith: Blood and protein loss via small intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet II (1987), 711-714.
9. Bridges, A. J., J. B. Marhall, A. A. Diaz-Arias: Acute eosinophilic colitis and hypersensitivity reaction associated with naproxen therapy. Amer. J. Med. 89 (1990), 526-527.
10. Campell, K., R. J. C. Steele: Non-steroidal anti-inflammatory drugs complicated diverticular disease. Brit. J. Surg. 78 (1991), 190-191.
11. Carratu, R., P. Parisi, A. Agozzino: Segmental ischaemic colitis with non-steroidal anti-inflammatory drugs. J. Clin. Gastroenterol. 16 (1993), 31-40.
12. Carson, J., W. M. Notis, E. S. Orris: Colonic ulceration and bleeding during diclofenac therapy. New Engl. J. Med. 323 (1990), 135.
13. Coates, A. G., T. T. Nostraut, J. A. P. Wilson: Esophagitis caused by non-steroidal anti-inflammatory medication. South. Med. J. 79 (1986) 1094-1097.
14. Corder, A.: Steroidal, non-steroidal anti-inflammatory drugs and serious septic complications on the diverticular disease. Brit. Med. J. 295 (1987), 1238-1241.
15. Coutrot, S., D. Roland, J. Barbier, P. Van der Marcq, M. Alcalay, C. Matuchansky: Acute perforation of colonic diverticula associated with short-term indomethacin. Lancet II (1978), 1055-1056.
16. Day, T. K.: Intestinal perforation associated with osmotic slow release indomethacin capsules. Brit. Med. J. 287 (1983), 1671-1672.
17. Duggan, D. F., K. F. Hooke, R. M. Noll, K. W. Kwan: Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem. Pharmacol. 24 (1975), 1749-1754.
18. Eastwood, G. L., B. D. Beck, D. O. Castell: Beneficial effects of indomethacin on acid-induced esophagitis in cats. Dig. Dis. Sci. 26 (1981), 601-608.
19. El-Serag, H. B., A. Sonnenberg: Association of esophagitis and esophageal strictures with disease treated with non-steroidal anti-inflammatory drugs. Amer. J. Gastroenterol. 92 (1997), 52-36.
20. Evans, J. M. M., A. D. McMahon, F. E. Murray, D. G. McDevitt, T. M. MacDonald. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 40 (1997), 619-622.
21. Garcia Rodriguez, L. A., H. Jick: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343 (1994), 769-772.
22. Gentric, A., Y. L. Pennec: Diclofenac-induced pseudomembranous colitis. Lancet 340 (1992), 126-127.
23. Geczy, M., L. Peltier, R. Wolbach: Naproxen tolerability in the elderly. A summary report. J. Rheumatol. 14 (1987), 348-354.
24. Gibson, G. R., F. B. Whitacre, C. A. Ricotti: Colitis induced by non-steroidal anti-inflammatory drugs. Arch. Intern. Med. 152 (1992), 625-632.
25. Gut, A., F. Halter, Ch. Ruchti: Nichtsteroidale Antirheumatika und Azetylsalizylsäure. Schweiz. Med. Wschr. 126 (1996), 616-625.
26. Halter, F., B. Weber, T. Huber, F. Eigenmann, M. Frey, C. Ruchti: Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J. Clin. Gastroenterol. 61 (1993), 74-80.
27. Harris, D. W., P. R. Smith, C. H. J. Swan: Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease. Gut 19 (1978), 875-877.
28. Heller, S. R., I. W. Fellows, A. L. Ogilvie: Non-steroidal anti-inflammatory drugs and benign esophageal stricture. Brit. Med. J. 285 (1982), 167-168.
29. Kaufmann, H. J., H. L. Taubin: Non-steroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann. Intern. Med. 107 (1987), 513-516.
30. Kikendall, J. W., A. C. Friedmann, M. A. Oyewole: Pill-induced esophageal injury. Dig. Dis. Sci. 28 (1983), 174-182.
31. Kirsch, M.: Drug-induced ileal disease. A new entity in the differential diagnosis of Crohn's disease. South. Med. J. 87 (1994), 546.
32. Lanas, A., B. I. Hirschowitz: Significance of aspirin use in patients with esophagitis. J. Clin. Gastroenterol. 13 (1991), 622-627.
33. Lang, J., A. B. Price, A. J. Levi, M. Burke, J. M. Gumpel, I. Bjarnason: Diaphragm disease. J. Clin. Pathol. 41 (1988), 516-526.
34. Langman, M. J. S., L. Morgan, A. Worrall: Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Brit. Med. J. 290 (1985), 347-349.
35. Langman, M. J. S.: Ulcer complications and non-steroidal anti-inflammatory drugs. Amer. J. Med. 84 (1988), Suppl. 2A, 15-19.
36. Ledinghan, V., P. R. Mannant, J. Foucher: Non-steroidal anti-inflammatory drugs and variceal bleeding. A case-control study. J. Hepatol. 24 (1996), 570-573.
37. Rainsford, K. D.: Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Scand. J. Gastroenterol. 163 (1989), Suppl., 9-16.
38. Rampton, D. S., N. I. McNeil, M. Sarner: Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 24 (1983), 187-189.
39. Ridell, R. H., M. Tanaka, C. Mazzoleni: Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis. A case-control study. Gut 33 (1992), 683-686.
40. Ritschard, T., L. Filippini: Nebenwirkungen nicht-steroidaler Anti-rheumatika auf den unteren Intestinaltrakt. Dtsch. med. Wschr. 111 (1986), 1561-1564.
41. Rutherford, D., G. Stockdiff, D. W. Hammer-Hodges, A. Ferguson: Proctocolitis induced by salicylates. Brit. Med. J. 288 (1984), 794.
42. Schwartz, G. J., R. A. Levine, S. Petokas: Effects of acute administration of a prostaglandin E2 analog, trimoprostil, on esophageal motility in man. Amer. J. Gastroenterol. 82 (1987), 826-829.
43. Semble, E. L., W. C. Wu, D. O. Castell: Non-steroidal anti-inflammatory drugs and esophageal injury. Semin. Arthritis. Rheum. 19 (1989), 99-109.
44. Shirazi, S. S., W. L. Zike, M. Brubacher: Effect of aspirin, alcohol and pepsin on ionic permeability of esophageal mucosa. Surg. Forum 24 (1973), 242-246.
45. Smyth, R. L., D. van Velzen, A. R. Smyth, D. A. Lloyd, D. P. Heaf: Strictures of ascending colon in cystic fibrosis and high-strength pancreatic-enzymes. Lancet 343 (1994), 85-86.
46. Soll, A. H., W. M. Weinstein, J. Kurata, D. MacCarthy: Non-steroidal anti-inflammatory drugs and peptic ulcer disease. Ann. Intern. Med. 114 (1991), 307-319.
47. Sonnenberg, A.: Esophageal disease. In: Everhart. J. E. (Ed.): Digestive disease in the United States. Epidemiology and impact. NIH publication 94-1447. Washington DC (U. S. Government Printing, Washington, D. C. 1994), 299-356.
48. Spechler, S. J.: Epidemiology and natural history of gastro-esophageal reflux disease. Digestion 51 (1992), Suppl., 124-129.
49. Stewart, J. T., C. R. Pennington, R. Pringle: Anti-inflammatory drugs and bowel perforations and haemorrhage. Brit. Med. J. 290 (1985), 787-788.
50. Sturges, H. F., C. L. Krone: Ulceration and stricture of the jejunum in a patient on long-term indomethacin therapy. Amer. J. Gastroenterol. 59 (1973), 162-169.
51. Tanner, A. R., A. S. Raghunath: Colonic inflammation and non-teriodal anti-inflammatory drug administration. An assessment of the frequency of the problem. Digestion 41 (1988), 116-120.
52. Uribe, A., C. Johansson, P. Scezak, C. Rubio: Ulceration of the colon associated with naproxen and acetylsalicylic acid treatment. Gastrointest. Endosc. 32 (1986), 242-244.
53. Wilcox, C. M., L. N. Alexander, G. A. Cotsonis, W. S. Clark: Non-steroidal anti-inflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig. Dis. Sci. 42 (1997), 990.
54. Wilkins, W. E., M. G. Ridley, A. L. Pozniak: Benign strictures of the esophagus. Role of non-steroidal anti-inflammatory drugs. Gut 25 (1984), 478-480.
55. William, J., G.: Drug-induced esophageal injury. Brit. Med. J. 141 (1979), 3019-3021.
56. Wilson, R. G., A. N. Smith, I. M. C. Macintyre: Complications of diverticular disease and non-steroidal anti-inflammatory drugs. A prospective study. Brit. J. Surg. 77 (1990), 1103-1104.